The DOI matches its Crossref record; 111 of the 113 references it cites were found in a registry or an index.
Ageing and multiple sclerosis
Open accessAbstract
The factor that is most relevant and strongly associated with the clinical course of multiple sclerosis is chronological age. Very young patients exclusively have relapsing remitting disease, whereas those with later onset disease face a more rapid development of permanent disability. For people with progressive multiple sclerosis, the poor response to current disease modifying therapies might be related to ageing in the immune system and CNS. Ageing is also associated with increased risks of side-effects caused by some multiple sclerosis therapies. Both somatic and reproductive ageing processes might contribute to development of progressive multiple sclerosis. Understanding the role of ageing in immune and neural cell function in patients with multiple sclerosis might be key to halting non-relapse-related progression. The growing literature on potential therapies that target senescent cells and ageing processes might provide effective strategies for remyelination and neuroprotection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The efficacy of remyelination has been shown to depend on multiple factors such as, age, disease duration and lesion location.”
From BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis (2025) · cites this paper as [7]
Citations
Cites
DNA methylation-based biomarkers and the epigenetic clock theory of ageing
Horvath, S., & Raj, K. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0004-3 · Cited by 3,095
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
Montalban, X., Hauser, S. L., Kappos, L., Arnold, D. L., Bar-Or, A., Comi, G., de Seze, J., Giovannoni, G., Hartung, H.-P., Hemmer, B., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1606468 · Cited by 1,905
The ageing systemic milieu negatively regulates neurogenesis and cognitive function
Villeda, S. A., Luo, J., Mosher, K. I., Zou, B., Britschgi, M., Bieri, G., Stan, T. M., Fainberg, N., Ding, Z., Eggel, A., et al. (2011) · Nature · doi:10.1038/nature10357 · Cited by 1,763
Blackburn, E. H., Epel, E. S., & Lin, J. (2015) · Science · doi:10.1126/science.aab3389 · Cited by 1,596
Magliozzi, R., Howell, O. W., Vora, A., Serafini, B., Nicholas, R. S., Puopolo, M., Reynolds, R., & Aloisi, F. (2006) · Brain · doi:10.1093/brain/awm038 · Cited by 1,486
Microglial control of astrocytes in response to microbial metabolites
Rothhammer, V., Borucki, D. M., Tjon, E. C., Takenaka, M. C., Chao, C.-C., Ardura-Fabregat, A., de Lima, K. A., Gutiérrez-Vázquez, C., Hewson, P., Staszewski, O., et al. (2018) · Nature · doi:10.1038/s41586-018-0119-x · Cited by 1,051
Kappos, L., Bar-Or, A., Cree, B. A. C., Fox, R. J., Giovannoni, G., Gold, R., Vermersch, P., Arnold, D. L., Arnould, S., Scherz, T., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30475-6 · Cited by 942
Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine
Haghikia, A., Jörg, S., Duscha, A., Berg, J., Manzel, A., Waschbisch, A., Hammer, A., Lee, D.-H., May, C., Wilck, N., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.09.007 · Cited by 927
Review: microglia of the aged brain: primed to be activated and resistant to regulation
Norden, D. M., & Godbout, J. P. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2012.01306.x · Cited by 792
A lymphocyte–microglia–astrocyte axis in chronic active multiple sclerosis
Absinta, M., Maric, D., Gharagozloo, M., Garton, T., Smith, M. D., Jin, J., Fitzgerald, K. C., Song, A., Liu, P., Lin, J.-P., et al. (2021) · Nature · doi:10.1038/s41586-021-03892-7 · Cited by 768
Self-citation
Research works printed but not linked: 3
- Guan, 2015, Patients with multiple sclerosis show increased oxidative stress markers and somatic telomere length shortening, Mol Cell Biochem, 400, 183, 10.1007/s11010-014-2274-1 · DOI · Paper page
- Maggi, 2021, Chronic white matter inflammation and serum neurofilament levels in multiple sclerosis, Neurology, 97, e543, 10.1212/WNL.0000000000012326 · DOI
- Wolinsky, 2018, Prespecified subgroup analyses of ocrelizumab efficacy in patients with primary progressive multiple sclerosis from the phase 3 ORATORIO study, Int J MS Care, 20, 32
Cited by
Sorted by citations
Neuroinflammation: An astrocyte perspective
Lee, H., Lee, J.-H., Flausino, L. E., & Quintana, F. J. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adi7828 · Cited by 253
Scalfari, A., Traboulsee, A. L., Oh, J., Airas, L. M., Bittner, S., Calabrese, M., García‐Domínguez, J. M., Granziera, C., Greenberg, B. M., Hellwig, K., et al. (2024) · Annals of Neurology · doi:10.1002/ana.27034 · Cited by 107
Current and future role of MRI in the diagnosis and prognosis of multiple sclerosis
Rocca, M. A., Preziosa, P., Barkhof, F., Brownlee, W. J., Calabrese, M., Stefano, N. D., Granziera, C., Ropele, S., Toosy, A., Vidal‐Jordana, Á., et al. (2024) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2024.100978 · Cited by 94
Mechanosensitive Piezo1 channel in physiology and pathophysiology of the central nervous system
Zong, B., Yu, F., Zhang, X., Pang, Y., Zhao, W., Sun, P., & Li, L. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102026 · Cited by 82
Fabrication of MOF-based Nanozyme sensor arrays and their application in disease diagnosis
Wang, M., Zhang, H., Yan, S., Zhou, Y., Guo, X., An, D., Zhong, W., & Zhang, Y. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.216506 · Cited by 79
Metadata
- Authors
- Graves, J. S., Krysko, K. M., Hua, L. H., Absinta, M., Franklin, R. J. M., & Segal, B. M.
- Affiliations
- United States Department of Veterans Affairs (US)
- St. Michael's Hospital (CA)
- Cleveland Clinic (US)
- Johns Hopkins University (US)
- Wellcome/MRC Cambridge Stem Cell Institute (GB)
- The Ohio State University (US)
- Corresponding author
- Graves, Jennifer S
- ORCID
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2023-01
- Volume
- 22
- Issue
- 1
- Pages
- 66-77
- ISSN
- 1474-4422 (ISSN-L)
- OpenAlex
- W4303473149
- Cited by
- 260
- References
- 113
- Citations by year
- 2026: 74 · 2025: 84 · 2024: 68 · 2023: 33
- FWCI
- 7.62
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (am, 162 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- The Lancet Neurology (acceptedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- National Institute of Neurological Disorders and Stroke
- Multiple Sclerosis Society (MS50)
- Conrad N. Hilton Foundation (17313)
- Fondazione Cariplo (1677)
- Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
- Fondazione per la Ricerca Biomedica (1750327)
- Ohio State University
- Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge (203151/Z/16/Z)
- Wellcome Trust
- National Eye Institute
- National Institutes of Health (R01EY028350, R01EY029159, R01NS105385)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Oncology › Polyomavirus and related diseases
- Keywords
- multiple sclerosis, aging, age of onset, relapsing-remitting multiple sclerosis, progressive multiple sclerosis, disability progression, immunosenescence, disease-modifying therapy, adverse drug reactions, reproductive aging, cellular senescence, senolytics, remyelination, neuroprotection
- MeSH terms
- Aging, Disabled Persons, Persons with Disabilities, Humans, Multiple Sclerosis, Disease Progression, Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Relapsing-Remitting
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
